# FDA Inspection 1255809 - Novo Nordisk US Bio Production Inc. - March 05, 2025

Source: https://www.keypedia.com/records/fda_inspections/novo-nordisk-us-bio-production-inc/f0082142-f1d5-4fc9-943d-0c5592570da2
Source feed: FDA_Inspections

> FDA Inspection 1255809 for Novo Nordisk US Bio Production Inc. on March 05, 2025. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1255809
- Company Name: Novo Nordisk US Bio Production Inc.
- Inspection Date: 2025-03-05
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1292060 - 2025-12-09](https://www.keypedia.com/records/fda_inspections/novo-nordisk-us-bio-production-inc/b0077115-b9ef-46ae-81a7-75debc87bcbd)
- [FDA Inspection 1292060 - 2025-12-09](https://www.keypedia.com/records/fda_inspections/novo-nordisk-us-bio-production-inc/a689f4ae-d290-4d66-9352-157d363f500a)
- [FDA Inspection 1255809 - 2025-03-05](https://www.keypedia.com/records/fda_inspections/novo-nordisk-us-bio-production-inc/9fa640e5-e2b2-418e-970b-92fd150ce266)
- [FDA Inspection 1214482 - 2023-07-25](https://www.keypedia.com/records/fda_inspections/novo-nordisk-us-bio-production-inc/7ff90033-28ae-475d-a08e-04d19cc180a1)

Company: https://www.keypedia.com/companies/novo-nordisk-us-bio-production-inc/08f5214b-4db0-4d94-86ee-4ba9c3c28ea2

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d